School of Medicine
Showing 1-10 of 32 Results
Alice C. Fan
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
Clinical Instructor, Medicine - Vaden Health Center
Bio Diana Farid has worked for individual and public health for over 20 years. She has cared for patients in university, private practice and free clinic settings. She has provided public health education and health care in rural villages in Honduras, traveled through the Ukraine and Malaysia promoting peace, served at an international school in China, worked at the US Agency for International Development in human rights and has had active roles at both Physicians for Social Responsibility and Physicians for Human Rights. Her most recent public health efforts have centered around the fundamental role art plays in promoting wellness. She has served as a physician health consultant for "The Media Project", working with television and film writers and producers. And in 2009, as a producer with FiddleHeadFern Productions, she completed production of a documentary film, "American Rhythms" (americanrhythmsmovie.com/), which follows a group of 5th grade students at a Los Angeles urban elementary school and their experience of the positive psychological and emotional health effects of a tailored drumming program. Currently, Diana Farid cares for patients at Stanford's Vaden student health center while working on several writing projects.
John W. Farquhar, M.D.
Professor of Medicine and of Health Research and Policy, Emeritus
Current Research and Scholarly Interests Chronic disease prevention, epidemiology of chronic diseases, community-based education for disease prevention, global health, politics and public health.
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly Interests My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We use lentiviral mediated transduction of murine dendritic cells with immunoregulatory proteins for site specific and targeted immunotherapy. We have identified and characterized a gene (GRAIL) that seems to control T cell anergy. We have recently characterized a gene (Deaf1) that seems to play a major role in peripheral tolerance in T1D.
William Fearon, MD
Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
Professor of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly Interests Studies of the role of the vitamin D receptor in the action of 1,25-dihydroxyvitamin D, the active vitamin D hormone. Current efforts are evaluating the vitamin D receptor in breast and prostate cancer, osteoporosis and rickets.
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly Interests My laboratory investigates how oncogenes initiate and sustain tumorigenesis. I have developed model systems whereby I can conditionally activate oncogenes in normal human and mouse cells in tissue culture or in specific tissues of transgenic mice. In particular using the tetracycline regulatory system, I have generated a conditional model system for MYC-induced tumors. I have shown that cancers caused by the conditional over-expression of the MYC proto-oncogene regress with its inactivation.